Latest News about mrk
Recent news which mentions mrk
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
From Benzinga
This 1 Number Could Supercharge Pfizer Stock by 40% or More
February 09, 2022
From Motley Fool
From Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
From Benzinga
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
From InvestorPlace
From Motley Fool
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
From MarketWatch
From InvestorPlace
Mid-Day Market Update: Nasdaq Down 2%; Biophytis Shares Spike Higher
February 03, 2022
From Benzinga
Mid-Morning Market Update: US Stocks Open Lower After Disappointing Earnings From Meta Platforms
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Merck Coughs Up a Failure With Its "Pipeline in a Product"
February 03, 2022
From Motley Fool
Forecaster Yves Lamoureux has nailed several big market downturns. Here’s why he’s now turning bullish on stocks.
February 03, 2022
From MarketWatch
A Peek Into The Markets: Nasdaq Futures Tumble Following Downbeat Earnings From Meta
February 03, 2022
From Benzinga
3 Dividend Stocks That Can Make You Richer in February (and Beyond)
February 03, 2022
From Motley Fool
7 Stocks To Watch For February 3, 2022
February 03, 2022
From Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
From Benzinga
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
From InvestorPlace
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
February 02, 2022
From Benzinga
What This FDA News Could Mean for Pfizer
February 01, 2022
From Motley Fool
2 Incredibly Cheap Value Stocks to Buy in February
February 01, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.